NLM Logo

COVID-19 Serotherapy MeSH Descriptor Data 2023


MeSH Heading
COVID-19 Serotherapy
Tree Number(s)
E02.095.465.425.400.330.050.200
E05.478.550.520.050.200
Unique ID
D000093522
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000093522
Scope Note
Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.
Entry Term(s)
COVID-19 Convalescent Plasma Treatment
COVID-19 Convalescent Serum Treatment
COVID-19 Hyperimmune Globulin Therapy
COVID-19 Serum Therapy
COVID19 Hyperimmune Globulin Therapy
COVID19 Serotherapy
COVID19 Serum Therapy
Convalescent Plasma Treatment for Covid-19
Convalescent Serum Treatment for Covid-19
Coronavirus Disease 2019 Serotherapy
Coronavirus Disease-19 Serotherapy
Covid-19 Convalescent Sera Treatment
Hyperimmune Globulin Therapy for COVID-19
SARS-CoV-2 Convalescent Plasma Treatment
SARS-CoV-2 Convalescent Sera Treatment
SARS-CoV-2 Convalescent Serum Treatment
Public MeSH Note
2023; COVID-19 SEROTHERAPY was indexed under COVID-19 2020-2022, and IMMUNIZATION, PASSIVE 2020-2022
History Note
2023 (2020)
Date Established
2023/01/01
Date of Entry
2022/07/14
Revision Date
2022/07/14
COVID-19 Serotherapy Preferred
COVID-19 Convalescent Plasma Treatment Narrower
COVID-19 Hyperimmune Globulin Therapy Narrower
COVID-19 Convalescent Serum Treatment Narrower
page delivered in 0.153s